12:00 AM
 | 
Jul 22, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

General Electric sales and marketing update

General Electric's Clarient Diagnostic Services Inc. company launched the Hodgkin Lymphoma Profile by MultiOmyx test to aid in the diagnosis of CD30-positive lymphoma with difficult morphology or otherwise insufficient...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >